Seems like the company would not be stating this if a buyout was a possibility:

"We will also aggressively seek partnerships, especially with big pharmaceuticals who have experienced recent failures in their NASH trials.”

I'd be happy with a successful trial meeting endpoints for now. The rest will take care of itself.